News » AIDS

1 thru 10 of 1225 Stories
Positive Phase 3 Data for Darunavir-based Single Tablet Regimen for HIV

Positive Phase 3 Data for Darunavir-based Single Tablet Regimen for HIV

Jul 26
Yesterday, in an oral session at the 9th International AIDS Society Conference on HIV Science in Paris, Janssen-Cilag International NV announced that an investigational single-tablet regimen (STR) containing darunavir is effective and well tolerated.

Studies Show Progress in Finding New HIV Prevention Options and Implementing Existing Approaches

Studies Show Progress in Finding New HIV Prevention Options and Implementing Existing Approaches

Jul 26
Researchers released data from five cutting-edge studies that show progress across several major HIV prevention approaches at an official press conference at the 9th IAS Conference on HIV Science.

CIPHER Grants and Fellowships Encourage Innovative Responses To Pediatric And Adolescent HIV

CIPHER Grants and Fellowships Encourage Innovative Responses To Pediatric And Adolescent HIV

Jul 26
The International AIDS Society's (IAS's) Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) has awarded research grants to six exceptional early-stage investigators at the 9th IAS Conference on HIV Science.

Study Finds Effective HIV Treatment Halts Transmission Among Same-Sex Couples

Study Finds Effective HIV Treatment Halts Transmission Among Same-Sex Couples

Jul 26
Results from the largest study to analyze HIV transmission risk among homosexual couples with differing HIV status have shown that HIV-positive men who are on treatment that makes the virus undetectable, do not transmit HIV to their partners.

Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable HIV Regimen

Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable HIV Regimen

Jul 26
Janssen Sciences announced that a regimen of two investigational long-acting, injectable formulations of HIV medicines was as effective as 3-drug ART.

HIV Epidemic 'Coming Under Control' in Nation with Top Rate

HIV Epidemic 'Coming Under Control' in Nation with Top Rate

Jul 26
The United States government says the HIV epidemic is "coming under control" in the country with the world's highest prevalence of HIV, Swaziland.

Gilead Announces Phase 3 Results for Investigational Fixed-Dose HIV Treatment

Gilead Announces Phase 3 Results for Investigational Fixed-Dose HIV Treatment

Jul 25
Gilead Sciences, Inc. announced detailed 48-week results from two Phase 3 studies evaluating the efficacy and safety of a fixed-dose combination of HIV meds.

MSF Sounds Alarm Over High Numbers of People Dying from AIDS in Sub-Saharan Africa

MSF Sounds Alarm Over High Numbers of People Dying from AIDS in Sub-Saharan Africa

Jul 25
Doctors Without Borders says an unacceptably high number of people from sub-Saharan Africa have been left out of the global HIV response.

amfAR's Kenneth Cole Launches End AIDS Coalition at 9th International AIDS Conference on HIV Science

amfAR's Kenneth Cole Launches End AIDS Coalition at 9th International AIDS Conference on HIV Science

Jul 25
Today at the IAS, Kenneth Cole launched the End AIDS Coalition (EAC) - a collaboration working together to end the AIDS epidemic by 2030.

Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine

Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine

Jul 25
Johnson & Johnson announced encouraging first-in-human clinical data for an investigational HIV-1 vaccine regimen in development at its Janssen Pharmaceutical Companies.

1 thru 10 of 1225 Stories